SCHEMBL26420615

SCHEMBL26420615

c1ccc(-c2ccc(N(c3ccccc3)c3ccc4c(c3)sc3cccc(-c5ccc(-c6nc(-c7ccccc7)nc(-c7ccccc7)n6)cc5)c34)cc2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIMK1 P53667 2/20 0.37
F9 P00740 1/20 0.34
ADORA2A P29274 1/20 0.32
ADORA1 P30542 1/20 0.32
APP P05067 1/20 0.32
ALDH1A1 P00352 3/20 0.31
MAPT P10636 3/20 0.31
HPGD P15428 3/20 0.31
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
ABCG2 Q9UNQ0 1/20 0.31
SLC9A1 P19634 1/20 0.31
KDM4E B2RXH2 2/20 0.31
LMNA P02545 2/20 0.31
GLA P06280 2/20 0.31
ABCB1 P08183 1/20 0.31
KDM1A O60341 1/20 0.31
PDE5A O76074 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP3A4 P08684 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26420483 0.95 LIMK1 (0.32) LIMK1F9ADORA2AADORA1APP
SCHEMBL26420480 0.95 LIMK1 (0.32) LIMK1F9ADORA2AADORA1APP
SCHEMBL25980424 0.95 LIMK1 (0.34) LIMK1F9ADORA2AADORA1APP
SCHEMBL26420515 0.95 LIMK1 (0.32) LIMK1F9ADORA2AADORA1APP
SCHEMBL26420532 0.94 LIMK1 (0.33) LIMK1F9ADORA2AADORA1APP
SCHEMBL25849543 0.93 LIMK1 (0.33) LIMK1F9ADORA2AADORA1ALDH1A1
SCHEMBL26420495 0.93 LIMK1 (0.33) LIMK1F9ADORA2AADORA1APP
SCHEMBL25853351 0.93 ADORA2A (0.33) LIMK1F9ADORA2AADORA1APP
SCHEMBL25850585 0.92 MEN1 (0.36) LIMK1F9ADORA2AADORA1ALDH1A1
SCHEMBL25849400 0.92 LIMK1 (0.32) LIMK1F9ADORA2AADORA1ABCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230320211-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-10-05 US disclosed
US-20230320211-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230320211-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE ORC3, CRY1, SUN2 LIMK1 104/4885F9 831/4885ADORA2A 2928/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.